Answers are grounded in this paper and cite their sources.
Oral semaglutide demonstrated consistently greater HbA1c and body weight reductions across a range of patient characteristics, with greater HbA1c reductions seen at higher baseline HbA1c levels.
No takes yet. Share an insight, caveat, or question.
Aroda et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: